Detalles de la búsqueda
1.
Cytomegalovirus Triplex vaccine in pediatric hematopoietic stem cell transplant patients at high risk for cytomegalovirus complications: evaluation of vaccine safety, immunogenicity and impact on viremia requiring antivirals.
Haematologica
; 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38426277
2.
A phase II randomized, placebo-controlled, multicenter trial to evaluate the efficacy of cytomegalovirus PepVax vaccine in preventing cytomegalovirus reactivation and disease after allogeneic hematopoietic stem cell transplant.
Haematologica
; 2024 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38328852
3.
Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus-specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis.
Am J Hematol
; 98(4): 588-597, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36594185
4.
Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical Trial.
Ann Intern Med
; 172(5): 306-316, 2020 03 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32040960
5.
Rapid Acquisition of Cytomegalovirus-Specific T Cells with a Differentiated Phenotype, in Nonviremic Hematopoietic Stem Transplant Recipients Vaccinated with CMVPepVax.
Biol Blood Marrow Transplant
; 25(4): 771-784, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30562587
6.
Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
J Virol
; 92(19)2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30045984
7.
MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults.
Blood
; 129(1): 114-125, 2017 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27760761
8.
Identification of a Continuous Neutralizing Epitope within UL128 of Human Cytomegalovirus.
J Virol
; 91(6)2017 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28077639
9.
Adoptive transfer of functional SARS-COV-2-specific immunity from donor graft to hematopoietic stem cell transplant recipients.
Am J Hematol
; 97(11): E404-E407, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36053823
10.
Correction for Chiuppesi et al., "Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Responses against Human Cytomegalovirus in Mice".
J Virol
; 93(23)2019 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31723009
11.
High-throughput screen using a single-cell tyrosine phosphatase assay reveals biologically active inhibitors of tyrosine phosphatase CD45.
Proc Natl Acad Sci U S A
; 109(35): 13972-7, 2012 Aug 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-22891353
12.
Highly stable and immunogenic CMV T cell vaccine candidate developed using a synthetic MVA platform.
NPJ Vaccines
; 9(1): 68, 2024 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38555379
13.
Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice.
Blood
; 118(8): 2159-69, 2011 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-21719601
14.
Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant.
J Infect Dis
; 205(8): 1294-304, 2012 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22402037
15.
Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study.
Front Immunol
; 14: 1114131, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36936918
16.
Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular Therapy.
Vaccines (Basel)
; 11(9)2023 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37766168
17.
Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates.
NPJ Vaccines
; 7(1): 7, 2022 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35064109
18.
Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity.
Blood Adv
; 6(6): 1645-1650, 2022 03 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35008104
19.
Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants.
iScience
; 25(8): 104745, 2022 Aug 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35846380
20.
Synthetic Multiantigen MVA Vaccine COH04S1 Protects Against SARS-CoV-2 in Syrian Hamsters and Non-Human Primates.
bioRxiv
; 2021 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34545366